Примери за използване на Acute pulmonary на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Acute pulmonary oedema.
Roots tyazhisty(bronchitis or other acute pulmonary disease).
Acute pulmonary edema causes significant breathing difficulties and can appear without warning.
In active form of tuberculosis and acute pulmonary diseases;
In trials on mice with acute pulmonary disease, the researchers succeeded in dampening the inflammation.
Abnormal build-up of fluid in the lungs(acute pulmonary oedema).
Interstitial pneumonitis, acute pulmonary oedema Gastrointestinal disorders.
Patients with a build-up of fluids in the lungs(acute pulmonary oedema).
The treatment of acute pulmonary infections in children and adolescents with cystic fibrosis will take 10-14 days.
Children and growing adolescents except for the treatment of acute pulmonary exacerbations of.
Patients with concomitant acute pulmonary infections, COPD and severe asthma should be carefully monitored.
Along with breathing difficulties,other signs and symptoms of acute pulmonary edema may include.
The effects include respiratory depression, acute pulmonary edema, bronchospasm, aspiration of vomit and aspiration pneumonia.
Nitric oxide, used for the prevention oreffective treatment of acute pulmonary hypertension.
It can be acute pulmonary insufficiency, inflammation and infection of mild genesis, problems with the function of the liver, heart and other internal organs.
Brain damage commonly observed in acute pulmonary process and often occurs suddenly.
The experts ran through a carefully designed, detailed simulation of a new(fictional)viral illness called CAPS or coronavirus acute pulmonary syndrome.
Children and growing adolescents except for the treatment of acute pulmonary exacerbations of cystic fibrosis in children aged 5 to 17 years.
Acute pulmonary oedema has been observed when nicardipine has been used as tocolytic during pregnancy(see section 4.8), especially in cases of multiple pregnancy(twins or more), with the intravenous route and/or concomitant use of beta-2 agonists.
The use of morphine, heroin orcodeine may affect blood pressure and cause acute pulmonary edema, coma and death.
Consequently, if PAH patients develop acute pulmonary oedema when treated with ambrisentan, the possibility ofpulmonary veno-occlusive disease should be considered.
In the Phase II trial,Multistem patients had significantly fewer incidents of pneumonia, acute pulmonary distress and other serious complications.
Indications approved for children andadolescents in most European countries include acute pulmonary exacerbations of patients with cystic fibrosis caused by Pseudomonas aeruginosa, complicated urinary tract infections, pyelonephritis, and post-exposure prophylaxis of inhalational anthrax.
The emergence of parenteral P. aeruginosaresistance to aztreonam or other beta-lactam antibiotics may have potential consequences for the treatment of acute pulmonary exacerbations with systemic antibiotics.
Treatment of acute Deep Vein Thrombosis(DVT) and treatment of acute Pulmonary Embolism(PE), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.
If something like this happens acutely, the heart has no time to adapt to these pressure changes, andso you get what you call flash pulmonary edema or acute pulmonary edema, and the person may go into congestive heart failure.
Treatment of adults with acute Deep Vein Thrombosis(DVT) and treatment of acute Pulmonary Embolism(PE), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.
In addition, rare cases of pulmonary infiltrates, acute respiratory distress syndrome, pneumonia, pneumonitis, pleural effusion,respiratory distress, acute pulmonary oedema and respiratory insufficiency have been reported.
For the treatment of acute pulmonary infections caused by Pseudomonas aeruginosa bacteria in children and adolescents(5-17 years) with cystic fibrosis 15 mg of ciprofloxacin per kg body weight is administered twice daily or 10 mg ciprofloxacin per kg body weight is administered three times daily(maximum 1200 mg daily).
These include, but are not limited to, pulmonary infiltrates, acute respiratory distress syndrome, pneumonia, pneumonitis, pleural effusion,respiratory distress, acute pulmonary oedema and respiratory insufficiency(see section 4.4).